Position in INCY
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$6,461
+$4,108 QoQ
Shares Held
57
+128.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#768
of 854 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in INCY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Strengthening Families & Communities, LLC holds $134,814 across 20 Biotechnology names. INCY ranks #5 (4.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CGON |
CG Oncology, Inc.
|
1,008 | $71,618 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
25 | $15,588 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
14 | $6,954 | |
| 4 | VTVT |
vTv Therapeutics Inc.
|
173 | $6,513 | |
| 5 | INCY |
Incyte Corp
This page
|
57 | $6,461 | |
| 6 | VKTX |
Viking Therapeutics, Inc.
|
150 | $5,851 | |
| 7 | BMRN |
Biomarin Pharmaceutical Inc
|
79 | $4,520 | |
| 8 | CRSP |
CRISPR Therapeutics AG
|
60 | $3,272 |
All Filings in INCY
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,461 | 57 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $2,353 | 25 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $987 | 10 | Shares | Sole | 2026-02-03 | |
| 2025-09-30 | $848 | 10 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $681 | 10 | Shares | Sole | 2025-07-24 | |
| 2025-03-31 | $605 | 10 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $1 | 10 | Shares | Sole | 2025-01-29 | |
| 2024-09-30 | $661 | 10 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $1 | 10 | Shares | Sole | 2024-07-22 | |
| No filing history on record for this holder in this stock. | ||||||